Rolf Warta

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Diffusion Weighted

Tyrosine Kinase

Top Venues

International journal of molecular sciences

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Catharina Lotsch, Rolf Warta, Christel Herold-Mende
The Molecular and Immunological Landscape of Meningiomas. International journal of molecular sciences 25 (17) (2024)
Valentina Fermi, Rolf Warta, Amélie Wöllner, Catharina Lotsch, Lena Jassowicz, Carmen Rapp, Maximilian Knoll, Gerhard Jungwirth, Christine Jungk, Philip Dao Trong, Andreas von Deimling, Amir Abdollahi, Andreas W Unterberg, Christel Herold-Mende
Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia/macrophages by treatment with GW2580. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Philip Dao Trong, Gerhard Jungwirth, Andreas Unterberg, Christel Herold-Mende, Rolf Warta
The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells. Cells 12 (8) (2023)
Philip Dao Trong, Gerhard Jungwirth, Andreas Unterberg, Christel Herold-Mende, Rolf Warta
The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells. Cells 12 (8) (2023)
Philip Dao Trong, Gerhard Jungwirth, Andreas Unterberg, Christel Herold-Mende, Rolf Warta
The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells. Cells 12 (8) (2023)
Gerhard Jungwirth, Tao Yu, Fang Liu, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Amir Abdollahi, Rolf Warta, Andreas W Unterberg, Christel Herold-Mende
Pharmacological Landscape of FDA-approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Gerhard Dyckhoff, Christel Herold-Mende, Sabine Scherer, Peter K Plinkert, Rolf Warta
Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma. Cancers 14 (15) (2022)
Gerhard Dyckhoff, Rolf Warta, Christel Herold-Mende, Elisabeth Rudolph, Peter K Plinkert, Heribert Ramroth
Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients. Cancers 13 (7) (2021)
Gerhard Dyckhoff, Rolf Warta, Christel Herold-Mende, Volker Winkler, Peter K Plinkert, Heribert Ramroth
Chemoradiotherapy but Not Radiotherapy Alone for Larynx Preservation in T3. Considerations from a German Observational Cohort Study. Cancers 13 (14) (2021)
Elena Schnabel, Maximilian Knoll, Christian Schwager, Rolf Warta, Andreas Mock, Benito Campos, Laila König, Christine Jungk, Wolfgang Wick, Andreas Unterberg, Jürgen Debus, Christel Herold-Mende, Amir Abdollahi
Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy. International journal of molecular sciences 22 (6) (2021)
Tao Yu, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Andreas Mock, Cihan Erkut, Amir Abdollahi, Rolf Warta, Andreas Unterberg, Christel Herold-Mende, Gerhard Jungwirth
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo. Cancers 13 (23) (2021)
Gerhard Dyckhoff, Rolf Warta, Christel Herold-Mende, Elisabeth Rudolph, Peter K Plinkert, Heribert Ramroth
An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment. Cancers 13 (3) (2021)
Philip Dao Trong, Gerhard Jungwirth, Tao Yu, Stefan Pusch, Andreas Unterberg, Christel Herold-Mende, Rolf Warta
Large-Scale Drug Screening in Patient-Derived IDHmut Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents. Cells 9 (6) (2020)
Jemma Dunn, Vasileios P Lenis, David A Hilton, Rolf Warta, Christel Herold-Mende, Clemens O Hanemann, Matthias E Futschik
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma. Cancers 12 (11) (2020)
Anastasia Makarevic, Carmen Rapp, Steffen Dettling, David Reuss, Christine Jungk, Amir Abdollahi, Andreas von Deimling, Andreas Unterberg, Christel Herold-Mende, Rolf Warta
Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant Glioma. International journal of molecular sciences 21 (20) (2020)
Christine Jungk, Rolf Warta, Andreas Mock, Sara Friauf, Bettina Hug, David Capper, Amir Abdollahi, Jürgen Debus, Martin Bendszus, Andreas von Deimling, Andreas Unterberg, Christel Herold-Mende
Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma. Cancers 11 (1) (2019)
Philip Dao Trong, Saskia Rösch, Heimo Mairbäurl, Stefan Pusch, Andreas Unterberg, Christel Herold-Mende, Rolf Warta
Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma. International journal of molecular sciences 19 (10) (2018)